A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
12/2009
12/24/2009	US20090318452 INHIBITORS OF p38
12/24/2009	US20090318401 Use of estriol in low doses
12/24/2009	US20090317464 Methods and compositions for producing anti-androgenic effects
12/23/2009	EP2134720A1 Heterocyclic spiro-compounds
12/23/2009	EP1539205B1 Phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof
12/23/2009	EP1259487B1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
12/23/2009	CN101607931A Preparation method of calcitriol
12/23/2009	CN100572363C New imidazole derivative, method for producing the same and use of the same
12/23/2009	CN100571748C Oral Chinese-medicinal composition for treating hyperthyroidism
12/22/2009	US7635684 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
12/22/2009	US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
12/22/2009	US7635674 insulin and carrieres, a second pharmaceutical composition containing O-(3-piperidino-2-hydroxy-1-propyl)nicotinic amidoxime ( BGP-15) and carriers; prediabetic state, metabolic X-syndrome, insulin sensitivity, glucose tolerance, dislipidemia or diabetes mellitus
12/22/2009	CA2538095C Selective androgen receptor modulators and methods of use thereof
12/22/2009	CA2452558C A synergistic pharmaceutical combination for the prevention or treatment of diabetes
12/22/2009	CA2444719C Method of production of an isomaltulose-containing enteral nutrient
12/22/2009	CA2415214C Phosphotetrahydropyran compounds
12/22/2009	CA2405593C Macrolides
12/22/2009	CA2373909C Multilayer drug form release in the colon
12/22/2009	CA2369587C Solubilized pharmaceutical composition for parenteral administration
12/22/2009	CA2368108C Thienopyrimidine compounds, their production and use
12/17/2009	WO2009152171A1 Corticosteroid linked beta-agonist compounds for use in therapy
12/17/2009	WO2009087467A3 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases
12/17/2009	US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009	US20090311349 Method of quantification of multiple bioactives from botanical compositions
12/17/2009	US20090311326 Pulmonary Insulin Crystals
12/17/2009	CA2727082A1 Suppression of neuroendocrine diseases
12/16/2009	EP2133090A1 Growth hormone secretion stimulator
12/16/2009	EP2131656A2 Phthalazine derivatives
12/16/2009	CN101605762A Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
12/16/2009	CN101602652A Method for extracting resveratrol from moraceae plants
12/16/2009	CN101601675A Pregnane steroids for use in the treatment of CNS disorders
12/16/2009	CN101601674A Pregnane steroids for use in the treatment of cns disorders
12/16/2009	CN101601672A Application of penehyclidine hydrochloride oral cavity partial drug administration as dental surgery medicine
12/16/2009	CN101601653A Prednicarbate lipidosome cream
12/16/2009	CN101601652A Momestasone furoate lipidosome cream
12/16/2009	CN101601650A Fluticasone propionate lipidosome cream
12/16/2009	CN100569747C Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof
12/15/2009	US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/10/2009	WO2009149139A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/10/2009	WO2009148052A1 Sulfonamide compound and application thereof
12/10/2009	WO2009148004A1 Novel compound and pharmaceutical application of same
12/10/2009	WO2009146811A1 C-ring-substituted pregn-4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter
12/10/2009	WO2009111428A3 Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates, and therapeutic uses thereof
12/10/2009	US20090306046 Method of treatment of hormone depletion induced vasomotor symptoms
12/10/2009	US20090305991 33 Human Secreted Proteins
12/10/2009	US20090305965 Stabilized Parathyroid Hormone Composition Comprising Parathyroid Hormone, Buffer and Stabilizing Agent
12/10/2009	US20090304830 Composition Comprising Bamboo Extract for Androgen Agonist
12/10/2009	US20090304821 Pharmaceutical Combination
12/10/2009	US20090304788 Encapsulated materials and methods for encapsulating materials
12/10/2009	US20090304623 Once A Day Formulation for Phosphate Binders
12/10/2009	CA2726855A1 C-ring-substituted pregn-4-ene-21,17-carbolactones, and pharmaceutical products comprising the same
12/10/2009	CA2726610A1 Sulfonamide compounds and use thereof
12/10/2009	CA2726449A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/09/2009	EP2131198A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
12/09/2009	EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009	EP2130548A2 Growth Hormone Releasing Peptides
12/09/2009	EP2130544A2 Processes for obtaining lignan extracts and compositions containing the lignan extracts
12/09/2009	EP2130535A1 Application of isoflavones for the production of medicine
12/09/2009	EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
12/09/2009	CN101597337A Conjugate of hydroxyalkyl starch and an active agent
12/09/2009	CN101597321A LHRH antagonist with long-acting low-histamine release side effect
12/09/2009	CN101596290A Traditional Chinese medicine for treating hyperthyroidism
12/09/2009	CN101596223A Method for enriching ginkgetin compound
12/09/2009	CN100567253C Novel succinate salt of O-demethyl-venlafaxine
12/08/2009	US7629468 Neuroprotectants, analgesics or anticonvulsants
12/08/2009	US7629381 Such as picropodophyllin, for the inhibition of the insulin-like growth factor-1 receptor; cancer, psoriasis, artherosclerosis and acromegaly
12/08/2009	US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009	US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009	US7629335 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour
12/08/2009	US7629318 Immunosuppressant compounds, methods and uses related thereto
12/08/2009	US7629146 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent; inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth, or any other processes that involve the migration of cells in vivo
12/08/2009	US7629005 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
12/08/2009	US7628988 Induce cell differentiation; process control
12/08/2009	US7628981 Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/08/2009	CA2510797C Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/08/2009	CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009	CA2399802C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/08/2009	CA2389025C Hormonal composition based on a progesterone and an oestrogen and use thereof
12/08/2009	CA2292846C Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
12/08/2009	CA2218116C Pulmonary delivery of aerosolized medicaments
12/03/2009	WO2009146365A1 Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists
12/03/2009	WO2009146097A1 Raloxifene pharmaceutical formulations
12/03/2009	WO2009145690A1 Method and means for treating viral disease, in particular hiv/aids
12/03/2009	WO2009144527A1 A new metformin glycinate salt for blood glucose control
12/03/2009	WO2009144278A2 USES OF CONGLUTIN-γ
12/03/2009	US20090298886 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
12/03/2009	US20090298765 Metastin derivatives and use thereof
12/03/2009	US20090297566 Oxygen-impervious packaging with optional oxygen scavenger, stabilized thyroid hormone compositions and methods for storing thyroid hormone pharmaceutical compositions
12/03/2009	CA2729035A1 A new metformin glycinate salt for blood glucose control
12/03/2009	CA2726264A1 Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists
12/03/2009	CA2726247A1 Method and means for treating viral disease, in particular hiv/aids
12/03/2009	CA2726231A1 Uses of conglutin-y
12/02/2009	EP2128253A1 Anti-fgf23 antibody and pharmaceutical composition comprising the same
12/02/2009	EP2127665A1 Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes
12/02/2009	EP2125859A2 Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors
12/02/2009	EP2125858A2 Pharmaceutically acceptable salts of 11-(4-aminophenyl)-19-norpregna-4,9(10)-diene-3,20-dione derivatives
12/02/2009	EP2125719A1 Bazedoxifene bis-phosphorates
12/02/2009	EP2125003A2 Use of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles
12/02/2009	EP2124951A1 5-cyan0-4- (pyrrolo ý2, 3b¨pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
12/02/2009	EP2124938A1 Topical formulation

1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 290